
All episodes
SCOUT· 60%43m·2026-01-15·Money

Would You Rather?: Goldman Sachs or The Mag7… And Structure Therapeutics CEO 1/15/26
CNBC's "Fast Money"
Goldman Sachs surging to fresh records as earnings top estimates, while some Mag7 stocks continue to struggle against the broader market. So will the big bank keep bumping, or can the big tech trouble make a turnaround? Plus the weight loss drug wars are heating up, with focus turning to the GLP-1 pill. The latest…
Buzzmeter · cross-platform

60%
SCOUT
Scout bees are checking it out — divided opinions, the swarm hasn't committed.
Hive Vote · Skep listeners
New on SkepAwaiting the hive's first votes
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
Recent reviews
- No reviews yet — be the first.
More from CNBC's "Fast Money"
See all episodes →One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.